Pemetrexed-Loaded Nanoparticles Targeted to Malignant Pleural Mesothelioma Cells: An in Vitro Study

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s186344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes

Cancers
Cancer ResearchOncology
2019English

Polymeric Films Loaded With Cisplatin for Malignant Pleural Mesothelioma: A Pharmacokinetic Study in an Ovine Model

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

MA12.09 Preclinical Investigations of Folate Receptor Targeted Nanoparticles for Photodynamic Therapy of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Heterogeneity in Malignant Pleural Mesothelioma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Cul4A Is an Oncogene in Malignant Pleural Mesothelioma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2011English

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2014English

P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients With Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Malignant Cells From Pleural Fluids in Malignant Mesothelioma Patients Reveal Novel Mutations

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy